These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 20100855)

  • 41. IL-10 is a major mediator of sepsis-induced impairment in lung antibacterial host defense.
    Steinhauser ML; Hogaboam CM; Kunkel SL; Lukacs NW; Strieter RM; Standiford TJ
    J Immunol; 1999 Jan; 162(1):392-9. PubMed ID: 9886412
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E; Bensman J; Lou M; Agnello M; Shriner K; Wong-Beringer A
    Crit Care Med; 2014 Jan; 42(1):48-56. PubMed ID: 23963124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vivo phospholipase activity of the Pseudomonas aeruginosa cytotoxin ExoU and protection of mammalian cells with phospholipase A2 inhibitors.
    Phillips RM; Six DA; Dennis EA; Ghosh P
    J Biol Chem; 2003 Oct; 278(42):41326-32. PubMed ID: 12915403
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The molecular mechanism of acute lung injury caused by Pseudomonas aeruginosa: from bacterial pathogenesis to host response.
    Sawa T
    J Intensive Care; 2014; 2(1):10. PubMed ID: 25520826
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alveolar response to Pseudomonas aeruginosa: role of the type III secretion system.
    Ader F; Le Berre R; Faure K; Gosset P; Epaulard O; Toussaint B; Polack B; Nowak E; Viget NB; Kipnis E; Guery BP
    Infect Immun; 2005 Jul; 73(7):4263-71. PubMed ID: 15972518
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producing Pseudomonas aeruginosa.
    Plotkowski MC; Estato V; Santos SA; da Silva MC; Miranda AS; de Miranda PE; Pinho V; Tibiriça E; Morandi V; Teixeira MM; Vianna A; Saliba AM
    Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26187894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural basis of cytotoxicity mediated by the type III secretion toxin ExoU from Pseudomonas aeruginosa.
    Gendrin C; Contreras-Martel C; Bouillot S; Elsen S; Lemaire D; Skoufias DA; Huber P; Attree I; Dessen A
    PLoS Pathog; 2012; 8(4):e1002637. PubMed ID: 22496657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple domains are required for the toxic activity of Pseudomonas aeruginosa ExoU.
    Finck-Barbançon V; Frank DW
    J Bacteriol; 2001 Jul; 183(14):4330-44. PubMed ID: 11418575
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mice Lacking γδ T Cells Exhibit Impaired Clearance of Pseudomonas aeruginosa Lung Infection and Excessive Production of Inflammatory Cytokines.
    Omar T; Ziltener P; Chamberlain E; Cheng Z; Johnston B
    Infect Immun; 2020 May; 88(6):. PubMed ID: 32229615
    [No Abstract]   [Full Text] [Related]  

  • 50. The galU Gene of Pseudomonas aeruginosa is required for corneal infection and efficient systemic spread following pneumonia but not for infection confined to the lung.
    Priebe GP; Dean CR; Zaidi T; Meluleni GJ; Coleman FT; Coutinho YS; Noto MJ; Urban TA; Pier GB; Goldberg JB
    Infect Immun; 2004 Jul; 72(7):4224-32. PubMed ID: 15213167
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intoxication of host cells by the T3SS phospholipase ExoU: PI(4,5)P2-associated, cytoskeletal collapse and late phase membrane blebbing.
    Sato H; Frank DW
    PLoS One; 2014; 9(7):e103127. PubMed ID: 25061861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Atypical Response Regulator AtvR Is a New Player in Pseudomonas aeruginosa Response to Hypoxia and Virulence.
    Kaihami GH; Breda LCD; de Almeida JRF; de Oliveira Pereira T; Nicastro GG; Boechat AL; de Almeida SR; Baldini RL
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28533471
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions between effector proteins of the Pseudomonas aeruginosa type III secretion system do not significantly affect several measures of disease severity in mammals.
    Shaver CM; Hauser AR
    Microbiology (Reading); 2006 Jan; 152(Pt 1):143-152. PubMed ID: 16385124
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ExoU is a potent intracellular phospholipase.
    Sato H; Frank DW
    Mol Microbiol; 2004 Sep; 53(5):1279-90. PubMed ID: 15387809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Early production of IL-17 protects against acute pulmonary Pseudomonas aeruginosa infection in mice.
    Liu J; Feng Y; Yang K; Li Q; Ye L; Han L; Wan H
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):179-88. PubMed ID: 21204996
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interactions of the effector ExoU from
    Springer TI; Reid TE; Gies SL; Feix JB
    J Biol Chem; 2019 Dec; 294(50):19012-19021. PubMed ID: 31662432
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of the Galleria mellonella caterpillar as a model host to study the role of the type III secretion system in Pseudomonas aeruginosa pathogenesis.
    Miyata S; Casey M; Frank DW; Ausubel FM; Drenkard E
    Infect Immun; 2003 May; 71(5):2404-13. PubMed ID: 12704110
    [TBL] [Abstract][Full Text] [Related]  

  • 58. High frequency of the exoU+/exoS+ genotype associated with multidrug-resistant "high-risk clones" of Pseudomonas aeruginosa clinical isolates from Peruvian hospitals.
    Horna G; Amaro C; Palacios A; Guerra H; Ruiz J
    Sci Rep; 2019 Jul; 9(1):10874. PubMed ID: 31350412
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia.
    Tsai WC; Strieter RM; Mehrad B; Newstead MW; Zeng X; Standiford TJ
    Infect Immun; 2000 Jul; 68(7):4289-96. PubMed ID: 10858247
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early Growth Response 1 Deficiency Protects the Host against Pseudomonas aeruginosa Lung Infection.
    Pang Z; Raudonis R; McCormick C; Cheng Z
    Infect Immun; 2019 Dec; 88(1):. PubMed ID: 31611276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.